Followers | 17 |
Posts | 5025 |
Boards Moderated | 0 |
Alias Born | 03/29/2019 |
Tuesday, September 06, 2022 2:31:42 PM
Recent KTRA News
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/04/2024 08:10:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:05:09 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/30/2024 09:20:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/25/2024 09:27:10 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/25/2024 09:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 09:00:09 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/24/2024 12:35:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 12:30:08 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/20/2024 08:20:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:15:07 PM
- Kintara Therapeutics Announces Adjournment of Special Meeting of Stockholders until October 4, 2024 • PR Newswire (US) • 09/20/2024 01:25:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/18/2024 12:40:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 12:35:07 PM
- Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences • PR Newswire (US) • 09/18/2024 12:30:00 PM
- Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences • PR Newswire (US) • 09/18/2024 12:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/11/2024 12:40:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 12:35:09 PM
- Kintara Therapeutics Provides Update on Corporate Developments and REM-001 Clinical Study • PR Newswire (US) • 09/11/2024 12:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/09/2024 08:10:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:05:10 PM
- Kintara Therapeutics to Hold Special Meeting of Stockholders to Allow for Completion of the Proposed Merger with TuHURA Biosciences, Inc. • PR Newswire (US) • 09/09/2024 12:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/03/2024 09:25:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 09:20:24 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/19/2024 01:10:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 01:05:08 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM